PI3K/mTOR activity sensitizes cancer cells to nucleolar stress
Myriam Barz, Alba Corman, Maria Häggblad, Alicia Gonzalez-Serrano, Louise Lidemalm, Matilde Murga, Daniela Hühn, Óscar Fernández-Capetillo
The paper identifies genetic factors that influence cancer cells' sensitivity to nucleolar stress-inducing drugs through CRISPR screens, revealing roles for P53, RB1, and PI3K/mTOR signaling.
bioRxiv · Nov 12, 2025 · PreprintCell Biology